Request for Covid-19 Impact Assessment of this Report

Take Action
Medical Devices

Global Cancer Gene Therapy Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • GLO2788376
  • 129 Pages
  • October 2018
  • Medical Devices
Download Sample    Get Discount   
 
Cancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has been discovered that the immune system could be manipulated to influence cancerous cells to destroy itself.

Scope of the Report:

This report studies the Cancer Gene Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cancer Gene Therapy market by product type and applications/end industries.

Several unmet medical needs for treatment of cancer have encouraged R&D of cancer gene therapy. Various factors, such as increasing prevalence of cancer, rising government initiatives, increasing funding from various government and non-government organizations, are driving the global cancer gene therapy market. In addition, ethical acceptance of gene therapy for treatment of diseases and growing popularity of DNA vaccines is driving the global cancer gene therapy market. However, less awareness and high cost involved in treatment are restraining the growth of global market for cancer gene therapy.

Americas will the major revenue contributor to this market due to the huge investment in the R&D activities for the healthcare segment to curb the rising number of cancer-related deaths in the region. The region’s focus on R&D has resulted in the emergence of several new treatment options that have long-term effect with minimum side effects.

The global Cancer Gene Therapy market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cancer Gene Therapy.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Adaptimmune

Bluebird bio

Celgene

Shanghai Sunway Biotech

Shenzhen SiBiono GeneTech

SynerGene Therapeutics

Altor BioScience

Amgen

Argenx

BioCancell

GlaxoSmithKline

Merck

OncoGenex Pharmaceuticals

Transgene

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Oncolytic Virotherapy

Gene Transfer

Gene-Induced Immunotherapy

Market Segment by Applications, can be divided into

Hospitals

Diagnostics Centers

Research Institutes

Table of Contents

1 Cancer Gene Therapy Market Overview

1.1 Product Overview and Scope of Cancer Gene Therapy

1.2 Classification of Cancer Gene Therapy by Types

1.2.1 Global Cancer Gene Therapy Revenue Comparison by Types (2017-2023)

1.2.2 Global Cancer Gene Therapy Revenue Market Share by Types in 2017

1.2.3 Oncolytic Virotherapy

1.2.4 Gene Transfer

1.2.5 Gene-Induced Immunotherapy

1.3 Global Cancer Gene Therapy Market by Application

1.3.1 Global Cancer Gene Therapy Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospitals

1.3.3 Diagnostics Centers

1.3.4 Research Institutes

1.4 Global Cancer Gene Therapy Market by Regions

1.4.1 Global Cancer Gene Therapy Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Cancer Gene Therapy Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Cancer Gene Therapy Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Gene Therapy Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Cancer Gene Therapy Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Gene Therapy Status and Prospect (2013-2023)

1.5 Global Market Size of Cancer Gene Therapy (2013-2023)

2 Manufacturers Profiles

2.1 Adaptimmune

2.1.1 Business Overview

2.1.2 Cancer Gene Therapy Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Adaptimmune Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)

2.2 Bluebird bio

2.2.1 Business Overview

2.2.2 Cancer Gene Therapy Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Bluebird bio Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)

2.3 Celgene

2.3.1 Business Overview

2.3.2 Cancer Gene Therapy Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Celgene Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)

2.4 Shanghai Sunway Biotech

2.4.1 Business Overview

2.4.2 Cancer Gene Therapy Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Shanghai Sunway Biotech Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)

2.5 Shenzhen SiBiono GeneTech

2.5.1 Business Overview

2.5.2 Cancer Gene Therapy Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)

2.6 SynerGene Therapeutics

2.6.1 Business Overview

2.6.2 Cancer Gene Therapy Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 SynerGene Therapeutics Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)

2.7 Altor BioScience

2.7.1 Business Overview

2.7.2 Cancer Gene Therapy Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Altor BioScience Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)

2.8 Amgen

2.8.1 Business Overview

2.8.2 Cancer Gene Therapy Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Amgen Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)

2.9 Argenx

2.9.1 Business Overview

2.9.2 Cancer Gene Therapy Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Argenx Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)

2.10 BioCancell

2.10.1 Business Overview

2.10.2 Cancer Gene Therapy Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 BioCancell Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)

2.11 GlaxoSmithKline

2.11.1 Business Overview

2.11.2 Cancer Gene Therapy Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 GlaxoSmithKline Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)

2.12 Merck

2.12.1 Business Overview

2.12.2 Cancer Gene Therapy Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Merck Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)

2.13 OncoGenex Pharmaceuticals

2.13.1 Business Overview

2.13.2 Cancer Gene Therapy Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)

2.14 Transgene

2.14.1 Business Overview

2.14.2 Cancer Gene Therapy Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Transgene Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)

3 Global Cancer Gene Therapy Market Competition, by Players

3.1 Global Cancer Gene Therapy Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Cancer Gene Therapy Players Market Share

3.2.2 Top 10 Cancer Gene Therapy Players Market Share

3.3 Market Competition Trend

4 Global Cancer Gene Therapy Market Size by Regions

4.1 Global Cancer Gene Therapy Revenue and Market Share by Regions

4.2 North America Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

4.3 Europe Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

4.5 South America Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

5 North America Cancer Gene Therapy Revenue by Countries

5.1 North America Cancer Gene Therapy Revenue by Countries (2013-2018)

5.2 USA Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

5.3 Canada Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

5.4 Mexico Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

6 Europe Cancer Gene Therapy Revenue by Countries

6.1 Europe Cancer Gene Therapy Revenue by Countries (2013-2018)

6.2 Germany Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

6.3 UK Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

6.4 France Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

6.5 Russia Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

6.6 Italy Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Cancer Gene Therapy Revenue by Countries

7.1 Asia-Pacific Cancer Gene Therapy Revenue by Countries (2013-2018)

7.2 China Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

7.3 Japan Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

7.4 Korea Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

7.5 India Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

8 South America Cancer Gene Therapy Revenue by Countries

8.1 South America Cancer Gene Therapy Revenue by Countries (2013-2018)

8.2 Brazil Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

8.3 Argentina Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

8.4 Colombia Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Cancer Gene Therapy by Countries

9.1 Middle East and Africa Cancer Gene Therapy Revenue by Countries (2013-2018)

9.2 Saudi Arabia Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

9.3 UAE Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

9.4 Egypt Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

9.5 Nigeria Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

9.6 South Africa Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

10 Global Cancer Gene Therapy Market Segment by Type

10.1 Global Cancer Gene Therapy Revenue and Market Share by Type (2013-2018)

10.2 Global Cancer Gene Therapy Market Forecast by Type (2018-2023)

10.3 Oncolytic Virotherapy Revenue Growth Rate (2013-2023)

10.4 Gene Transfer Revenue Growth Rate (2013-2023)

10.5 Gene-Induced Immunotherapy Revenue Growth Rate (2013-2023)

11 Global Cancer Gene Therapy Market Segment by Application

11.1 Global Cancer Gene Therapy Revenue Market Share by Application (2013-2018)

11.2 Cancer Gene Therapy Market Forecast by Application (2018-2023)

11.3 Hospitals Revenue Growth (2013-2018)

11.4 Diagnostics Centers Revenue Growth (2013-2018)

11.5 Research Institutes Revenue Growth (2013-2018)

12 Global Cancer Gene Therapy Market Size Forecast (2018-2023)

12.1 Global Cancer Gene Therapy Market Size Forecast (2018-2023)

12.2 Global Cancer Gene Therapy Market Forecast by Regions (2018-2023)

12.3 North America Cancer Gene Therapy Revenue Market Forecast (2018-2023)

12.4 Europe Cancer Gene Therapy Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Cancer Gene Therapy Revenue Market Forecast (2018-2023)

12.6 South America Cancer Gene Therapy Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Cancer Gene Therapy Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Cancer Gene Therapy Picture

Table Product Specifications of Cancer Gene Therapy

Table Global Cancer Gene Therapy and Revenue (Million USD) Market Split by Product Type

Figure Global Cancer Gene Therapy Revenue Market Share by Types in 2017

Figure Oncolytic Virotherapy Picture

Figure Gene Transfer Picture

Figure Gene-Induced Immunotherapy Picture

Table Global Cancer Gene Therapy Revenue (Million USD) by Application (2013-2023)

Figure Cancer Gene Therapy Revenue Market Share by Applications in 2017

Figure Hospitals Picture

Figure Diagnostics Centers Picture

Figure Research Institutes Picture

Table Global Market Cancer Gene Therapy Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2013-2023)

Table Adaptimmune Basic Information, Manufacturing Base and Competitors

Table Adaptimmune Cancer Gene Therapy Type and Applications

Table Adaptimmune Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)

Table Bluebird bio Basic Information, Manufacturing Base and Competitors

Table Bluebird bio Cancer Gene Therapy Type and Applications

Table Bluebird bio Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)

Table Celgene Basic Information, Manufacturing Base and Competitors

Table Celgene Cancer Gene Therapy Type and Applications

Table Celgene Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)

Table Shanghai Sunway Biotech Basic Information, Manufacturing Base and Competitors

Table Shanghai Sunway Biotech Cancer Gene Therapy Type and Applications

Table Shanghai Sunway Biotech Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)

Table Shenzhen SiBiono GeneTech Basic Information, Manufacturing Base and Competitors

Table Shenzhen SiBiono GeneTech Cancer Gene Therapy Type and Applications

Table Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)

Table SynerGene Therapeutics Basic Information, Manufacturing Base and Competitors

Table SynerGene Therapeutics Cancer Gene Therapy Type and Applications

Table SynerGene Therapeutics Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)

Table Altor BioScience Basic Information, Manufacturing Base and Competitors

Table Altor BioScience Cancer Gene Therapy Type and Applications

Table Altor BioScience Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)

Table Amgen Basic Information, Manufacturing Base and Competitors

Table Amgen Cancer Gene Therapy Type and Applications

Table Amgen Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)

Table Argenx Basic Information, Manufacturing Base and Competitors

Table Argenx Cancer Gene Therapy Type and Applications

Table Argenx Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)

Table BioCancell Basic Information, Manufacturing Base and Competitors

Table BioCancell Cancer Gene Therapy Type and Applications

Table BioCancell Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)

Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors

Table GlaxoSmithKline Cancer Gene Therapy Type and Applications

Table GlaxoSmithKline Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)

Table Merck Basic Information, Manufacturing Base and Competitors

Table Merck Cancer Gene Therapy Type and Applications

Table Merck Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)

Table OncoGenex Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table OncoGenex Pharmaceuticals Cancer Gene Therapy Type and Applications

Table OncoGenex Pharmaceuticals Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)

Table Transgene Basic Information, Manufacturing Base and Competitors

Table Transgene Cancer Gene Therapy Type and Applications

Table Transgene Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)

Table Global Cancer Gene Therapy Revenue (Million USD) by Players (2013-2018)

Table Global Cancer Gene Therapy Revenue Share by Players (2013-2018)

Figure Global Cancer Gene Therapy Revenue Share by Players in 2016

Figure Global Cancer Gene Therapy Revenue Share by Players in 2017

Figure Global Top 5 Players Cancer Gene Therapy Revenue Market Share in 2017

Figure Global Top 10 Players Cancer Gene Therapy Revenue Market Share in 2017

Figure Global Cancer Gene Therapy Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Cancer Gene Therapy Revenue (Million USD) by Regions (2013-2018)

Table Global Cancer Gene Therapy Revenue Market Share by Regions (2013-2018)

Figure Global Cancer Gene Therapy Revenue Market Share by Regions (2013-2018)

Figure Global Cancer Gene Therapy Revenue Market Share by Regions in 2017

Figure North America Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

Figure Europe Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

Figure South America Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

Table North America Cancer Gene Therapy Revenue by Countries (2013-2018)

Table North America Cancer Gene Therapy Revenue Market Share by Countries (2013-2018)

Figure North America Cancer Gene Therapy Revenue Market Share by Countries (2013-2018)

Figure North America Cancer Gene Therapy Revenue Market Share by Countries in 2017

Figure USA Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

Figure Canada Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

Figure Mexico Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

Table Europe Cancer Gene Therapy Revenue (Million USD) by Countries (2013-2018)

Figure Europe Cancer Gene Therapy Revenue Market Share by Countries (2013-2018)

Figure Europe Cancer Gene Therapy Revenue Market Share by Countries in 2017

Figure Germany Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

Figure UK Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

Figure France Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

Figure Russia Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

Figure Italy Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Cancer Gene Therapy Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Cancer Gene Therapy Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Cancer Gene Therapy Revenue Market Share by Countries in 2017

Figure China Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

Figure Japan Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

Figure Korea Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

Figure India Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

Table South America Cancer Gene Therapy Revenue by Countries (2013-2018)

Table South America Cancer Gene Therapy Revenue Market Share by Countries (2013-2018)

Figure South America Cancer Gene Therapy Revenue Market Share by Countries (2013-2018)

Figure South America Cancer Gene Therapy Revenue Market Share by Countries in 2017

Figure Brazil Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

Figure Argentina Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

Figure Colombia Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Cancer Gene Therapy Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Cancer Gene Therapy Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Cancer Gene Therapy Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Cancer Gene Therapy Revenue Market Share by Countries in 2017

Figure Saudi Arabia Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

Figure UAE Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

Figure Egypt Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

Figure Nigeria Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

Figure South Africa Cancer Gene Therapy Revenue and Growth Rate (2013-2018)

Table Global Cancer Gene Therapy Revenue (Million USD) by Type (2013-2018)

Table Global Cancer Gene Therapy Revenue Share by Type (2013-2018)

Figure Global Cancer Gene Therapy Revenue Share by Type (2013-2018)

Figure Global Cancer Gene Therapy Revenue Share by Type in 2017

Table Global Cancer Gene Therapy Revenue Forecast by Type (2018-2023)

Figure Global Cancer Gene Therapy Market Share Forecast by Type (2018-2023)

Figure Global Oncolytic Virotherapy Revenue Growth Rate (2013-2018)

Figure Global Gene Transfer Revenue Growth Rate (2013-2018)

Figure Global Gene-Induced Immunotherapy Revenue Growth Rate (2013-2018)

Table Global Cancer Gene Therapy Revenue by Application (2013-2018)

Table Global Cancer Gene Therapy Revenue Share by Application (2013-2018)

Figure Global Cancer Gene Therapy Revenue Share by Application (2013-2018)

Figure Global Cancer Gene Therapy Revenue Share by Application in 2017

Table Global Cancer Gene Therapy Revenue Forecast by Application (2018-2023)

Figure Global Cancer Gene Therapy Market Share Forecast by Application (2018-2023)

Figure Global Hospitals Revenue Growth Rate (2013-2018)

Figure Global Diagnostics Centers Revenue Growth Rate (2013-2018)

Figure Global Research Institutes Revenue Growth Rate (2013-2018)

Figure Global Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Cancer Gene Therapy Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Cancer Gene Therapy Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Cancer Gene Therapy Revenue Market Forecast (2018-2023)

Figure Europe Cancer Gene Therapy Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Cancer Gene Therapy Revenue Market Forecast (2018-2023)

Figure South America Cancer Gene Therapy Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Cancer Gene Therapy Revenue Market Forecast (2018-2023)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Medical Implants Market By Type (Orthopedic Implants, cardiac implants, Stents, Spinal Implants, Neurostimulators, dental implants, Breast Implants, facial Implants) and By Materials (Metallic, Ceramic, Polymers, Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...

  • Publish Date: August 21, 2016
  • $5370
View Details
Ostomy Drainage Bags Market by Type (Colostomy Bags, Ileostomy Bags, Urostomy Bags, Continent Urostomy Bags, and Continent Ileostomy Bags) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...

  • Publish Date: December 1, 2016
  • $5370
View Details
Laparoscopy Devices Market by Product (Laparoscopes, Energy Devices, Insufflators, Robot-Assisted Surgery Systems, Suction or Irrigation Systems, Closure Devices, Hand Instruments, Access Devices, Accessories, and Other Laparoscopy Devices), Application {General Surgery (Cholecystectomies, Hernia Repairs, Appendectomies, Anti-reflux Surgeries, and Others), Bariatric Surgery (Gastric Bypass, Sleeve gastrectomy, Gastric Banding, and Others), Gynecological Surgery, Urological Surgery, Colorectal Surgery, and Others}, and End User (Hospitals, Clinics, and Other End Users) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...

  • Publish Date: April 24, 2017
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research